1 小时
Zacks Investment Research on MSNABT Stock to Gain From FDA IDE Approval for Its Coronary IVL SystemAbbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...
Manipal Hospital Old Airport Road, Bengaluru, has appointed Dr. Keshava R as the Head of the Cardiology Department. With over ...
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...
Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果